Yoshida, H., Li, J., Inui, H., Rokugawa, K., Fujiwara, K. (2025). RECQL1 as a potential therapeutic target for PARP inhibitor-resistant ovarian cancer. Scientific Reports. https://doi.org/10.1038/s41598-025-21844-3